This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Hydrea 500 mg Hard Capsules PA2239/021/001 CHEPLAPHARM Arzneimittel GmbH | Hydroxycarbamide |
| Olmesartan/Amlodipine Clonmel 40 mg/10 mg film-coated tablets PA0126/293/003 Clonmel Healthcare Ltd | Olmesartan medoxomil & Amlodipine besilate |
| Valcyte 50 mg/ml powder for oral solution PA2239/023/002 CHEPLAPHARM Arzneimittel GmbH | Valganciclovir |
| Xolair 150 mg solution for injection in pre-filled syringe EU/1/05/319/8-10 Novartis Europharm Limited | Omalizumab |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Cefuroxime 750 mg powder for solution for injection/infusion PA2059/006/001 Fresenius Kabi Deutschland GmbH | Cefuroxime |
| Vancomycin 1000mg Powder for Concentrate for Solution for Infusion and Oral Solution PA1122/008/002 Noridem Enterprises Limited | Vancomycin |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA